William Blair Decreases Earnings Estimates for Penumbra

Penumbra, Inc. (NYSE:PEN) – Equities research analysts at William Blair dropped their FY2025 earnings per share (EPS) estimates for Penumbra in a research note issued on Wednesday, April 2nd. William Blair analyst M. Andrew now forecasts that the company will post earnings of $3.67 per share for the year, down from their previous estimate of $3.91. The consensus estimate for Penumbra’s current full-year earnings is $3.67 per share.

Other equities research analysts have also recently issued reports about the stock. Oppenheimer began coverage on shares of Penumbra in a research report on Tuesday, December 17th. They issued an “outperform” rating and a $275.00 price objective on the stock. JPMorgan Chase & Co. upped their price objective on Penumbra from $230.00 to $285.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. StockNews.com downgraded Penumbra from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Wells Fargo & Company upped their price target on Penumbra from $275.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 19th. Finally, Royal Bank of Canada raised their price target on shares of Penumbra from $285.00 to $313.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $294.47.

Penumbra Stock Up 0.5 %

Penumbra stock opened at $263.59 on Monday. The company has a 50 day moving average of $274.30 and a 200-day moving average of $246.41. The company has a quick ratio of 3.25, a current ratio of 6.01 and a debt-to-equity ratio of 0.02. Penumbra has a twelve month low of $148.00 and a twelve month high of $310.00. The stock has a market capitalization of $10.15 billion, a PE ratio of 775.25, a price-to-earnings-growth ratio of 2.83 and a beta of 0.56.

Penumbra (NYSE:PEN) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.88 by $0.09. The business had revenue of $315.52 million during the quarter, compared to analyst estimates of $311.63 million. Penumbra had a return on equity of 9.74% and a net margin of 1.17%.

Hedge Funds Weigh In On Penumbra

A number of large investors have recently made changes to their positions in the company. UMB Bank n.a. increased its position in Penumbra by 57.4% during the fourth quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $46,000 after acquiring an additional 70 shares during the period. Hurley Capital LLC bought a new position in shares of Penumbra during the fourth quarter worth approximately $56,000. Huntington National Bank raised its position in shares of Penumbra by 138.7% in the fourth quarter. Huntington National Bank now owns 265 shares of the company’s stock valued at $63,000 after buying an additional 154 shares in the last quarter. Mather Group LLC. boosted its stake in shares of Penumbra by 208.0% in the fourth quarter. Mather Group LLC. now owns 308 shares of the company’s stock valued at $73,000 after buying an additional 208 shares during the period. Finally, Versant Capital Management Inc increased its stake in Penumbra by 893.5% during the 1st quarter. Versant Capital Management Inc now owns 308 shares of the company’s stock worth $82,000 after acquiring an additional 277 shares during the period. Institutional investors own 88.88% of the company’s stock.

Insider Buying and Selling

In other Penumbra news, EVP Johanna Roberts sold 600 shares of the firm’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $287.43, for a total transaction of $172,458.00. Following the completion of the sale, the executive vice president now owns 66,539 shares of the company’s stock, valued at $19,125,304.77. This trade represents a 0.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Adam Elsesser sold 16,565 shares of Penumbra stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $272.24, for a total transaction of $4,509,655.60. Following the transaction, the chief executive officer now directly owns 52,495 shares of the company’s stock, valued at approximately $14,291,238.80. This trade represents a 23.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 111,236 shares of company stock worth $31,222,390. Company insiders own 5.00% of the company’s stock.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.